Delivery Order SPE2DR25D3303-SPE2DR26F65J3
Award Date 1/12/26
Potential Completion Date 2/3/26
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $11,895.72 by the Defense Logistics Agency on July 22, 2025, for the supply of INLYTA 5 mg tablets in quantities of 60 units. The contract, which carries a firm fixed-price structure with an ultimate completion date of August 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11.9K by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of INLYTA 5 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 24, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1.0B global...
- The Defense Logistics Agency awarded a $11,895.72 delivery order to AmerisourceBergen Drug Corp for INLYTA 5 mg tablets (60-count units) on August 19, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a $12.6K firm fixed-price delivery order to AmerisourceBergen Drug Corp for supply of Inlyta 1 mg tablets (180-count units), with a completion date of January 23, 2026. This non-set-aside contract represents a standard pharmaceutical procurement for federal medical supply needs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Inlyta 5 mg tablets (60-count units) with a ceiling value of $11,895.72. This non-set-aside contract, awarded on July 21, 2025, utilizes firm fixed pricing and is scheduled for completion by August 11, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of INLYTA 1 mg tablets (180 count) with a ceiling value of $12,565.63. This competitively awarded, non-set-aside contract was executed on November 20, 2025, with an ultimate completion date of December 12, 2025, under firm fixed price terms. The award represents a child delivery order issued against...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of INLYTA 5 mg tablets (60-count) valued at $11.9K under a firm fixed-price contract type. This delivery order, issued on October 22, 2025, with an ultimate completion date of November 13, 2025, represents a non-competitive set-aside award for pharmaceutical procurement to support federal medical supply needs. The award is performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $25,072.52 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of INLYTA 5 mg tablets (60-unit quantity), with completion scheduled for February 3, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of INLYTA 5 mg tablets (60 count) with a ceiling value of $12,536.26. This is a firm fixed-price delivery order with an ultimate completion date of December 22, 2025, and carries no set-aside designation, indicating it was competitively awarded. The contract will be performed at the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,536.26 to AmerisourceBergen Drug Corp for 60 tablets of INLYTA 5 mg on December 12, 2025. This firm fixed price, non-set-aside contract was performed at the vendor's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 6, 2026. INLYTA (axitinib) is a targeted cancer therapy medication used primarily in oncology treatment regimens, reflecting DLA's pharmaceutical procurement responsibilities...